Everyday Health Inc (EVDY), ANSYS, Inc. (ANSS), More: Why You Should Pay Attention To These Stocks

ChemoCentryx Inc (NASDAQ:CCXI) was also a new addition in Connective Capital Management’s portfolio as of the end of the second quarter. At the end of June, the fund had 191,881 shares of the company valued at $861,000. This investment was highly profitable, as the stock delivered 34.5% gains during the third quarter. Heading into the third quarter, a total of 12 of the hedge funds in our system were also set to profit off of the stock, holding long positions in it on June 30. The largest stake in ChemoCentryx Inc (NASDAQ:CCXI) was held by Biotechnology Value Fund / BVF Inc, which reported holding $36.7 million worth of stock as of June 30. It was followed by Sio Capital with a $2.9 million position. Other investors bullish on the company included Nantahala Capital Management and D E Shaw.

Lastly, there were 39,475 Hollysys Automation Technologies Ltd (NASDAQ:HOLI) shares in the portfolio of Connective Capital Management at the end of June. The net worth of these shares was $686,000, which would have increased to nearly $1 million in the third quarter, as Hollysys Automation’s stock returned 27.6%. Heading into the third quarter of 2016, 14 of the hedge funds in our database were shareholders of Hollysys, a 22% decline from one quarter earlier. Impax Asset Management was the largest shareholder of Hollysys Automation Technologies Ltd (NASDAQ:HOLI), with a stake worth $20.5 million reported as of the end of June. Trailing Impax Asset Management was Sloane Robinson Investment Management, which amassed a stake valued at $14.7 million. Royce & Associates, GLG Partners, and Millennium Management also held valuable positions in the company.

Disclosure: None